Steady-state pharmacokinetics of hydromorphone and hydromorphone-3-glucuronide in cancer patients after immediate and controlled-release hydromorphone

Journal of Clinical Pharmacology
N HagenA C Darke

Abstract

Although the pharmacokinetics of oral hydromorphone has been evaluated in healthy volunteers after small single oral doses, data are not available regarding the disposition of hydromorphone and its principal metabolite, hydromorphone-3-glucuronide (H3G), at steady-state and after large oral doses. The authors studied the pharmacokinetics of hydromorphone and H3G after oral administration of an immediate-release (IR) and controlled-release (CR) formulation of hydromorphone at a daily dose of 48 +/- 11 mg (range 6-216 mg) in a randomized, double-blind, steady-state, two-way crossover evaluation in 18 patients with chronic cancer pain. Controlled-release hydromorphone demonstrated equivalent bioavailability and acceptable CR characteristics, when compared with IR hydromorphone (CR vs. IR: AUC0-12 123.10 +/- 20.38 vs. 118.98 +/- 20.92 ng.hr.mL-1, P = NS, Cmax 17.76 +/- 3.07 vs. 19.70 +/- 4.04 ng.mL-1, P = NS, Cmin 6.04 +/- 1.01 vs. 5.28 +/- 1.000 ng.mL-1, P = NS, and Tmax 4.78 +/- 0.78 vs. 1.47 +/- 0.22 hr, P = 0.0008). A significant linear relationship existed between hydromorphone dose and hydromorphone AUC (r = 0.8315, P = 0.0001) and between hydromorphone AUC and H3G AUC (r = 0.8048, P = 0.0001) over a wide dose range. The stea...Continue Reading

References

Aug 1, 1975·Life Sciences·S H Pollock
Dec 1, 1977·Journal of Pharmaceutical Sciences·E J ConeC W Gorodetzky
Nov 1, 1992·Pain·N Babul, A C Darke
Nov 1, 1992·British Journal of Clinical Pharmacology·I ChoonaraJ Ratcliffe
Apr 1, 1992·Clinical Pharmacokinetics·V W SteinijansJ H Jonkman
Oct 1, 1990·Journal of Pain and Symptom Management·R K Portenoy, N Coyle
Apr 1, 1990·Journal of Pain and Symptom Management·D E Weissman
Sep 1, 1990·Clinical Pharmacology and Therapeutics·H J McQuayR A Moore
Jan 1, 1990·Life Sciences·M T SmithT Cramond
Oct 1, 1988·Clinical Pharmacology and Therapeutics·M M ReidenbergD E Drayer
Nov 1, 1989·British Journal of Clinical Pharmacology·I A ChoonaraA Rane
Dec 28, 1987·Life Sciences·G W PasternakC E Inturrisi
Dec 19, 1987·Lancet·H J McQuayJ W Sear
Mar 1, 1987·Annals of Clinical Biochemistry·C W HandJ W Sear
Jan 1, 1987·European Journal of Clinical Pharmacology·J Säwe, I Odar-Cederlöf
Jan 19, 1987·Life Sciences·G J CardinaleS Spector
Apr 1, 1985·British Journal of Clinical Pharmacology·J SäweA Rane
May 1, 1973·Proceedings of the Society for Experimental Biology and Medicine·S RoerigR I Wang
Sep 1, 1971·The Tohoku Journal of Experimental Medicine·K ShimomuraH Tsukamoto
Jan 1, 1983·Journal of Pharmaceutical Sciences·P Y GrabinskiR W Houde
Jan 1, 1983·European Journal of Clinical Pharmacology·J SäweA Rane
Jul 1, 1993·Archives of Disease in Childhood·R HartleyM I Levene

❮ Previous
Next ❯

Citations

Apr 1, 1995·Journal of Pain and Symptom Management·N BabulN Hagen
May 24, 2005·Journal of Pain and Symptom Management·Alison Murray, Neil A Hagen
Aug 6, 1998·Cancer Nursing·G VanegasF De Conno
Jun 17, 2011·The Clinical Journal of Pain·Howard S Smith
Mar 24, 2009·Paediatric Drugs·Boris ZernikowBrian J Anderson
Mar 1, 2002·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·M ZhengM C Ong
Jun 18, 2002·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·M ZhengM C Ong
Nov 17, 2010·Journal of Forensic Sciences·Robert MeatherallSusan Phillips
Apr 30, 2005·Journal of Palliative Medicine·K J Neely, D M Roxe
Aug 10, 2011·Journal of Palliative Medicine·Gobi ParamanandamDawn C Schwenke
Dec 22, 2007·Journal of Palliative Medicine·James F Cleary
Oct 27, 2004·Anesthesia and Analgesia·Anita C RudyDaniel P Wermeling
Apr 23, 2016·The Cochrane Database of Systematic Reviews·Philip J WiffenR Andrew Moore
May 24, 2007·Japanese Journal of Clinical Oncology·Katri Elina Clemens, Eberhard Klaschik
Nov 13, 2020·Anesthesia and Analgesia·Terhi J LohelaTuomas O Lilius

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.